HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Dik J Kwekkeboom Selected Research

3-Tyr-octreotide

3/2010Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
3/2010Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors.
6/2007Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues.
1/2005Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
4/2002Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Dik J Kwekkeboom Research Topics

Disease

28Neoplasms (Cancer)
11/2015 - 04/2002
24Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2016 - 04/2002
8Neoplasm Metastasis (Metastasis)
09/2012 - 04/2004
4Thyroid Neoplasms (Thyroid Cancer)
01/2007 - 04/2004
3Pituitary Neoplasms (Pituitary Adenoma)
04/2007 - 12/2003
2Sarcoidosis (Schaumann Disease)
12/2015 - 11/2011
2Thrombocytopenia (Thrombopenia)
12/2013 - 03/2010
2Pheochromocytoma
04/2008 - 01/2007
2Carcinoma (Carcinomatosis)
04/2008 - 04/2004
2Carcinoid Tumor (Carcinoid)
04/2008 - 08/2007
2Breast Neoplasms (Breast Cancer)
04/2004 - 04/2003
1Granuloma
12/2015
1Insulinoma
01/2015
1Hypercalcemia (Milk Alkali Syndrome)
09/2014
1Hyperglycemia
12/2013
1Fatigue
12/2013
1Vipoma (WDHA)
04/2008
1Diarrhea
04/2008
1Paraganglioma (Paragangliomas)
01/2007
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2007
1Renal Insufficiency (Renal Failure)
01/2007
1Cicatrix (Scar)
01/2006
1Fibrosis (Cirrhosis)
01/2005
1Necrosis
01/2005
1Melanoma (Melanoma, Malignant)
12/2003
1Hodgkin Disease (Hodgkin's Disease)
04/2003

Drug/Important Bio-Agent (IBA)

20Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
12/2015 - 04/2002
19Somatostatin Receptors (Somatostatin Receptor)IBA
12/2015 - 04/2002
15Peptide Receptors (Peptide Receptor)IBA
02/2016 - 04/2003
9Tyr(3)- octreotateIBA
11/2015 - 04/2002
8Octreotide (Sandostatin)FDA LinkGeneric
09/2012 - 04/2002
7Pentetic Acid (DTPA)FDA LinkGeneric
09/2012 - 04/2002
5Radioisotopes (Radionuclides)IBA
06/2012 - 04/2002
53-Tyr-octreotideIBA
03/2010 - 04/2002
4yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA
03/2010 - 01/2005
3pentetreotide (OctreoScan)FDA Link
05/2010 - 04/2003
3BombesinIBA
07/2009 - 12/2002
3Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
07/2009 - 04/2008
3Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
04/2007 - 12/2003
2HormonesIBA
09/2010 - 04/2008
2PeptidesIBA
05/2010 - 07/2009
2indium-111-octreotideIBA
07/2009 - 01/2005
1glucagon-like peptide receptor (receptor, glucagon-like peptide)IBA
01/2015
1Parathyroid Hormone-Related ProteinIBA
09/2014
1everolimusFDA Link
12/2013
1Alanine Transaminase (SGPT)IBA
12/2013
1adalimumab (Humira)FDA Link
11/2011
1Chromogranin AIBA
09/2011
1thymidine 5'-triphosphate (TTP)IBA
03/2010
1Substance PIBA
07/2009
1Cholecystokinin (Pancreozymin)IBA
07/2009
1NeuropeptidesIBA
07/2009
1GastrinsIBA
07/2009
1RadiopharmaceuticalsIBA
07/2009
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
04/2008
1SynaptophysinIBA
04/2008
1Dopamine Receptors (Dopamine Receptor)IBA
04/2007
1Protective AgentsIBA
01/2007
1InterferonsIBA
04/2006
1LutetiumIBA
01/2006
1YttriumIBA
01/2006
1papillary Thyroid cancerIBA
01/2005
1follicular Thyroid cancerIBA
01/2005
1hexamminecobalt(III) tricarbonatocobaltate(III)IBA
01/2005
1Factor IX (PTC)FDA LinkGeneric
01/2005
1minigastrinIBA
04/2004
1Cholecystokinin B ReceptorIBA
04/2004
1BenzamidesIBA
12/2003
1benzamideIBA
12/2003
1Uveal melanomaIBA
12/2003
1Gastrin-Releasing PeptideIBA
12/2002

Therapy/Procedure

5Aftercare (After-Treatment)
10/2013 - 01/2005
4Radiotherapy
09/2010 - 12/2002
3Drug Therapy (Chemotherapy)
07/2009 - 01/2005
1Neoadjuvant Therapy
11/2015
1Salvage Therapy
03/2010